SNOOPY: Staphylococcus aureus Network: ultrasound for diagnosis of endovascular disease in Paediatrics and Youth
We are inviting your child to take part in this sub-study because they have a Staph aureus bloodstream infection and have joined the SNAP platform or registry
(1) To find out how often blood clots occur in children with SAB
(2) To find out why blood clots occur (risk factors)
(3) To define children at high risk to recommend for targeted ultrasound screening.
This sub-study is being piloted in Australia at one to two paediatric tertiary hospital sites and may expand to more children’s hospital sites in future.
Lead Investigators: Prof Steve Tong, Prof Josh Davis, Dr Anita Campbell, A/Prof Asha Bowen, Ms Leanne Lamborn, Prof Derek Roebuck, Dr Tina Carter, Dr Julie Marsh, Dr Kate Stannage, Prof Chris Blyth, Dr Brendan McMullan, A/Prof Philip Britton, Miss Keerthi Anpalagan
Please read the below information to learn more about the test involved in this sub-study:
(1) The Staph aureus bloodstream infection is ongoing
(2) A new focus of infection is detected via imaging or clinically.
Additional data collected for this sub study will be stored in a separate database to the SNAP Trial.
This additional data includes:
All information collected for this sub study will be deidentified, meaning it will not be able to identify you.
This database is housed at the Perth Children’s Hospital and will be stored on a secure health server in Western Australia that is password encrypted and is only accessible to the sub study investigators.
Your information will be stored for at least 15 years after this sub study is completed.
You can withdraw from the study at any time, just notify a member of your child’s treating team and study investigators.
If you withdraw, we will keep any information we have collected about your child up until you withdraw. If you do not agree with this, you should not join the study.
Name: Dr Anita Campbell (study doctor and lead investigator)
Name: Miss Keerthi Anpalagan (Study Investigator)